We are live on ! Find out more
EAM

Eagle Asset Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 41.58%
This Fund
S&P 500
This Quarter Est. Return
+0.97%
1 Year Est. Return
+41.58%
3 Year Est. Return
+53.38%
5 Year Est. Return
+214.12%
10 Year Est. Return
+691.23%
AUM
$19.4B
AUM Growth
-$168M
Cap. Flow
+$84M
Cap. Flow %
0.43%
Top 10 Hldgs %
9.58%
Holding
697
New
57
Increased
245
Reduced
309
Closed
74

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$107M
2
NVS icon
Novartis
NVS
+$106M
3
WP
Worldpay, Inc.
WP
+$90.7M
4
MMM icon
3M
MMM
+$83.9M
5
AMP icon
Ameriprise Financial
AMP
+$78.5M

Sector Composition

Rank Sector Weight
1 Technology 19.63%
2 Healthcare 17.98%
3 Industrials 16.05%
4 Consumer Discretionary 12.24%
5 Financials 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVBG
201
DELISTED
Everbridge, Inc. Common Stock
EVBG
$29.8M 0.15%
483,018
+28,752
+6% +$2.44M
AVTR icon
202
Avantor
AVTR
$8B
$29.7M 0.15%
+2,022,977
New +$34.3M
ALGN icon
203
Align Technology
ALGN
$12.1B
$29.4M 0.15%
162,629
-109,762
-40% -$22.8M
HELE icon
204
Helen of Troy
HELE
$658M
$28.6M 0.15%
181,326
-23,821
-12% -$3.54M
QTWO icon
205
Q2 Holdings
QTWO
$3.62B
$28.3M 0.15%
358,673
+281
+0.1% +$23.2K
LLY icon
206
Eli Lilly
LLY
$1.07T
$28.1M 0.14%
251,136
+234,305
+1,392% +$26.1M
ABT icon
207
Abbott
ABT
$183B
$26.9M 0.14%
321,636
-22,405
-7% -$1.9M
INSM icon
208
Insmed
INSM
$22.9B
$26.9M 0.14%
1,524,798
+23,240
+2% +$449K
BLUE
209
DELISTED
bluebird bio
BLUE
$26.2M 0.14%
21,996
-6
-0% -$9.16K
ALB icon
210
Albemarle
ALB
$13.5B
$25.7M 0.13%
369,918
-223
-0.1% -$15.2K
DRNA
211
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$25.3M 0.13%
+1,765,156
New +$25.2M
EYE icon
212
National Vision
EYE
$1.67B
$25.1M 0.13%
1,043,359
-352,577
-25% -$10.3M
MSA icon
213
Mine Safety
MSA
$6.7B
$25.1M 0.13%
229,964
-3,320
-1% -$350K
GCO icon
214
Genesco
GCO
$409M
$25.1M 0.13%
626,332
+1,667
+0.3% +$64.3K
ARQL
215
DELISTED
Arqule Inc
ARQL
$25M 0.13%
3,488,358
+709,259
+26% +$6.66M
FOXF icon
216
Fox Factory Holding Corp
FOXF
$775M
$24.7M 0.13%
396,878
+53,683
+16% +$3.99M
HALO icon
217
Halozyme
HALO
$9.75B
$23.9M 0.12%
+1,540,616
New +$25.4M
RARX
218
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$23.8M 0.12%
1,005,884
+390,415
+63% +$11.6M
ATRA icon
219
Atara Biotherapeutics
ATRA
$71M
$23.1M 0.12%
65,406
+1,228
+2% +$458K
PGNX
220
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$22.8M 0.12%
4,504,094
+4,386
+0.1% +$21.9K
CPT icon
221
Camden Property Trust
CPT
$11.2B
$22.5M 0.12%
202,651
-13,642
-6% -$1.47M
FOLD
222
DELISTED
Amicus Therapeutics
FOLD
$22.2M 0.11%
2,768,660
+51,260
+2% +$556K
GBT
223
DELISTED
Global Blood Therapeutics, Inc.
GBT
$21.6M 0.11%
446,011
+9,050
+2% +$472K
EVH icon
224
Evolent Health
EVH
$448M
$21.6M 0.11%
3,002,480
+1,149,789
+62% +$8.25M
IOSP icon
225
Innospec
IOSP
$2.08B
$20.8M 0.11%
233,430
-29,232
-11% -$2.62M

Similar funds

Eagle Asset Management's Q3 2019 Portfolio in Review

As of Q3 2019, Eagle Asset Management held 697 positions worth $19.4B, down 0.86% from $19.6B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Eagle Asset Management's Q3 2019 filing shows 57 new, 245 increased, 309 reduced and 74 closed positions. Its largest new stake was Texas Instruments: 969,094 shares worth $125M. The largest sale was AT&T, an estimated $107M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Industrials.

  • Eagle Asset Management's largest Q3 2019 buy was Texas Instruments: 969,094 shares worth $125M.
  • Eagle Asset Management added most to Verizon in Q3 2019, an estimated $153M increase.
  • Eagle Asset Management's biggest Q3 2019 reduction was AT&T, cutting an estimated $107M.
  • Eagle Asset Management fully exited Worldpay, Inc. in Q3 2019, selling an estimated $90.7M.
  • Eagle Asset Management's ten largest holdings make up 9.6% of its $19.4B portfolio in Q3 2019.
  • Eagle Asset Management opened 57 new positions and closed 74 in Q3 2019.
  • Eagle Asset Management's portfolio value fell 0.86% quarter-over-quarter to $19.4B.

Based on Eagle Asset Management's 13F filing for Q3 2019, filed 4 Nov 2019.